Company Filing History:
Years Active: 2019
Title: Innovator Mohmed Ashmaig: Pioneering Advances in Lipoprotein Diagnostics
Introduction: Mohmed Ashmaig, based in Glen Allen, VA, is an inventor with a significant contribution to the field of cardiovascular diagnostics. With one registered patent to his name, his work revolves around enhancing the understanding and measurement of lipoprotein(a), a critical factor in assessing cardiovascular risk.
Latest Patents: Mohmed Ashmaig holds a patent titled "Lp(a) Subform Size Identification Using ELISA." This innovative patent describes methods for determining the particle number and/or molar mass of lipoprotein(a) subform(s) in a biological sample through enzyme-linked immunosorbent assay (ELISA). His methods not only improve existing lipoprotein ELISA techniques but also facilitate the quantification of Lp(a) particles in a rapid and cost-effective manner. This advancement provides a useful diagnostic tool for evaluating cardiovascular risk in individuals by enabling more precise measurements of specific Lp(a) subforms.
Career Highlights: Ashmaig’s career is marked by his dedication to developing methodologies that enhance diagnostic approaches in medical settings. His patent represents a significant leap forward in the capabilities of existing tests, moving beyond mere concentration measurements to a more nuanced analysis of lipoprotein(a) structures.
Collaborations: Throughout his career, Mohmed Ashmaig has collaborated with fellow colleagues Philip A. Guadagno and Erin Grace Summers Bellin. Together, they contribute to the innovative culture at True Health IP LLC, where they focus on creating health technologies that aim to transform patient diagnostics.
Conclusion: Mohmed Ashmaig's work is indicative of the essential role inventors play in advancing medical diagnostics. His patented methods for identifying lipoprotein(a) subform sizes not only improve current testing protocols but also pave the way for future innovations in cardiovascular risk assessment. The impact of such technologies can lead to better-informed decisions in patient care, ultimately contributing to healthier outcomes.